FDA Investigator: Debra L. Boyd Seale

- Debra L. Boyd Seale first started conducting FDA inspections in 2016, with the last inspection in 2023. Over that time, Debra L. Boyd Seale has conducted 53 inspections at 53 companies across 53 sites.

Get Debra Boyd Seale's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.

Documents

Upon purchase, you will receive an email with a link to immediately download the documents.

FDA 483 University of Texas Cancer Clinic Mobile, Houston | 2023

Out-of-stock
Debra L. Boyd Seale
Human Drugs Form 483

FDA 483 Morris Hospital and Silver Cross Hospital IRB, New Lenox | 2020

Out-of-stock
Debra L. Boyd Seale
Human Drug Form 483

FDA 483 AcelRx Pharmaceuticals, Inc., Redwood City | 2020

Out-of-stock
Debra L. Boyd Seale
Human Drug Form 483

FDA 483 Astellas Pharma US, Inc., Northbrook | 2019

Out-of-stock
Debra L. Boyd Seale
Human Drug Form 483

FDA 483 Anuj Bhargava MD, West Des Moines | 2019

Out-of-stock
Debra L. Boyd Seale
Human Drug Form 483

FDA 483 Luis F. Soruco, MD, Arlington Heights | 2019

Out-of-stock
Debra L. Boyd Seale
Biologic Form 483

FDA 483 Univ CO Boulder Institutional Review Board, Boulder | 2019

Out-of-stock
Debra L. Boyd Seale
Medical Devices & Rad Health Form 483

FDA 483 Pharmaron, Beijing | 2019

Out-of-stock
Debra L. Boyd Seale
Human Drug Form 483